Literature DB >> 70294

Cytomegalovirus-directed lymphocyte reactivity in healthy adults tested by a CMV-induced lymphocyte transformation test.

C H Ten Napel, T H The, J Bijker, G C De Gast, M M Langenhuysen.   

Abstract

A cytomegalovirus (CMV) induced lymphocyte tranformation test (LTT) performed as a microtechnique assay is described. Investigations were done in a group of twenty-five healthy adults with normal lymphocyte reactivity to phytohaemagglutinin and previously encountered antigens. Lymphocyte reactivity was established in CMV-seropositive persons using heat-inactivated cell-free CMV strain AD 169 in an optimal stimulating dose of 10(1-5) TCID 50. Positive CMV-LTT results were shown to be induced by purified inactivated CMV. Most persons (twelve out of seventeen) with antibodies against CMV-induced late or virus-structure antigens (LA) showed positive (stimulation index greater than 2-0) CMV-LTT results. Magnitude of CMV-LTT responses was positively related to the CMV-LA Ab titres (P less than 0-01). All persons (six) with antibodies against CMV early or non-structural antigens showed positive CMV-LTT results and highest stimulation rates were found in this group. Generally CMV-seronegative persons were non-responsive. Only in one case (LA Ab titre 10) a borderline positive response (stimulation index 2-3) was seen. The CMV-LTT was shown to have virus-specific properties because it was not related to simultaneously performed LTTs with Epstein-Barr virus and Herpes simplex virus in the same persons. It is concluded that CMV-LTTs are useful virus-specific in vitro techniques for the study of CMV-directed lymphocyte reactivity. Its possible relationship to other cell-mediated immunity tests and its practical applications are discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 70294      PMCID: PMC1541031     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Thymus dependence of viral antigens.

Authors:  W Burns; L C Billups; A L Notkins
Journal:  Nature       Date:  1975-08-21       Impact factor: 49.962

2.  In vitro stimulation of lymphocytes of donors seronegative for Epstein-Barr virus by preparations of inactivated Epstein-Barr virus.

Authors:  R S Chang; C A Spina
Journal:  J Infect Dis       Date:  1976-06       Impact factor: 5.226

3.  Differentiation of type 1 and type 2 herpes simplex virus by in vitro stimulation of immune lymphocytes.

Authors:  G L Rosenberg; C Wohlenberg; A J Nahmias; A L Notkins
Journal:  J Immunol       Date:  1972-08       Impact factor: 5.422

Review 4.  The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. I.

Authors:  T H Weller
Journal:  N Engl J Med       Date:  1971-07-22       Impact factor: 91.245

5.  Immunofluorescence in cells derived from Burkitt's lymphoma.

Authors:  G Henle; W Henle
Journal:  J Bacteriol       Date:  1966-03       Impact factor: 3.490

6.  Development of a vaccine against mental retardation caused by cytomegalovirus infection in utero.

Authors:  S D Elek; H Stern
Journal:  Lancet       Date:  1974-01-05       Impact factor: 79.321

7.  Immunologic functions of isolated human lymphocyte subpopulations. II. Antigen triggering of T and B cells in vitro.

Authors:  L Chess; R P MacDermott; S F Schlossman
Journal:  J Immunol       Date:  1974-10       Impact factor: 5.422

8.  Antibody reactions to virus-specific early antigens (EA) in patients with cytomegalovirus (CMV) infection.

Authors:  T H The; G Klein; M M Langenhuysen
Journal:  Clin Exp Immunol       Date:  1974-01       Impact factor: 4.330

9.  In vitro stimulation of sensitized lymphocytes by herpes simplex virus and vaccinia virus.

Authors:  G L Rosenberg; P A Farber; A L Notkins
Journal:  Proc Natl Acad Sci U S A       Date:  1972-03       Impact factor: 11.205

View more
  11 in total

1.  Cytomegalovirus early and late membrane antigens detected by antibodies in human convalescent sera.

Authors:  J M Middeldorp; J Jongsma; T H The
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

2.  Human immune responses to herpes simplex virus, varicella-zoster and cytomegalovirus in vitro.

Authors:  S A Williamson; N Parish; J D Chambers; R A Knight
Journal:  Immunology       Date:  1986-03       Impact factor: 7.397

3.  Mitogenic activity in human embryonic fibroblasts early after infection by human cytomegalovirus.

Authors:  N Takehara; K Ryoke; T Kurimura
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

4.  In vitro stimulation of lymphocytes by different strains of cytomegalovirus.

Authors:  L Gärtner; J A Wilhelm; R Czieschnek
Journal:  Med Microbiol Immunol       Date:  1982       Impact factor: 3.402

5.  Longitudinal studies of cytomegalovirus-specific cell-mediated immunity in congenitally infected infants.

Authors:  M Okabe; S Chiba; T Tamura; Y Chiba; T Nakao
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

6.  Maintenance of cytomegalovirus (CMV) latency and host immune responses of long term renal allograft survivors. I. Prolonged suppression of in vitro lymphocyte responses against CMV infected fibroblasts related to previous secondary CMV infection.

Authors:  H W Roenhorst; J M Middeldorp; J M Beelen; J Schirm; A M Tegzess; T H The
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

7.  Lymphocyte blastogenesis and interferon production in adult human leukocyte cultures stimulated with cytomegalovirus antigens.

Authors:  S E Starr; B Dalton; T Garrabrant; K Paucker; S A Plotkin
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

8.  Cytomegalovirus-specific lymphocyte transformations in subjects of different ages with primary immunodeficiency.

Authors:  T Tamura; S Chiba; W Abo; Y Chiba; T Nakao
Journal:  Infect Immun       Date:  1980-04       Impact factor: 3.441

9.  The cellular immune response to cell-associated and cell-free cytomegalovirus (CMV) antigens after primary CMV-infection in non-immunocompromised hosts: development and maintenance of CMV-latency and its influence on immunocompetence.

Authors:  H W Roenhorst; C G Kallenberg; T H The
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

10.  Blastogenic response of human lymphocytes to early antigen(s) of human cytomegalovirus.

Authors:  J L Waner; N Kong; S Biano
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.